Charles River Laboratories International, Inc. (NYSE: CRL) provides essential drug discovery, non-clinical development, safety assessment, and manufacturing solutions to the pharmaceutical, biotechnology, and medical device industries world…
HQ: Wilmington, MA, United States of Americawww.criver.com
USD337.97-0.83%vs prev. close
Performance
1W
+0.13%
1M
+11.91%
3M
+20.68%
1Y
+99.73%
YTD
+69.43%
Valuation
P/E
371.4
EPS TTM
0.91
Dividend yield
—
Size and risk
Market cap
$16.2B
Beta
1.34
Price history
CRL price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Charles River Labs
CRL
Diagnostics & Research
Mkt cap (USD bn)
16.2
P/E
371.4
Div yld
—
1W
+0.1%
1M
+11.9%
3M
+20.7%
6M
+124.0%
1Y
+99.7%
YTD
+69.4%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Charles River Labs
CRL
Diagnostics & Research
16.2
371.4
—
+0.1%
+11.9%
+20.7%
+124.0%
+99.7%
+69.4%
Subscribe to Equity Analytics to compare CRL with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.